DELIVERY ORDER
Active75N98026F00001
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH OLAO
$382.8K
obligated · signed 3 months ago
PHASE 1 SINGLE ASCENDING DOSE PHARMACOKINETICS STUDY. ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT. JULY 20, 2026 - JANUARY 19, 2028. TASK ORDER 01. DAP-NCAP-00000009
Performance timeline
Start
Jul 20, 2026
End
Jan 19, 2028
with all options
Loading status
Estimated start: Jan 19, 2027
MRIGLOBAL
Contract 75N98026F00001
UEI
HKQHNFKNKL15
Parent Company
MRIGLOBAL
Capabilities & Certifications
Headquarters Location
Congressional District: 05
Current Obligation
$382,839
Base + Exercised Options
$382,839
Total Ceiling Value
$382,839
Contract Type
COST PLUS FIXED FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Place of Performance
Congressional District: 05
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH OLAO
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIDA
Office
Contract Vehicle
75N98026D00031
IDCDepartment of Health and Human Services
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.